Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 10, 2008, Pages 977-984

  Barth, R E ^a   Van Der Meer, J T M ^b   Hoepelman, A I M ^a   Schrooders, P A ^c   Van De Vijver, D A ^d   Geelen, S P M ^d   Tempelman, H A ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Ndlovu Medical Centre   (South Africa)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RIFAMPICIN; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RURAL AREA; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; RNA, VIRAL; RURAL POPULATION; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 53549121685     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0534-2     Document Type: Article

References (35)

1. World Health Organization (WHO) (2004) Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. WHO, Geneva, Switzerland. Available online at: http://www.who.int/hiv/pub/ prev_care/en/arvrevision2003en.pdf
2. Panel on clinical practices for the treatment of HIV infection, convened by the DHHS (2008) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, January 29, 2008. Available online at: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
3. Panel on clinical practices for the treatment of HIV infection, convened by the DHHS (2008) Guidelines for the use of antiretroviral agents in pediatric HIV infection, February 28, 2008. Available online at: http://aidsinfo.nih.gov/ ContentFiles/PediatricGuidelines.pdf
4. M Egger M May G Chêne AN Philips B Ledergerber F Dabis D Costagliola A D'Arminio Monforte F de Wolf P Reiss JD Lundgren AC Justice S Staszewski C Leport RS Hogg CA Sabin MJ Gill B Salzberger JA Sterne ART Cohort Collaboration 2002 Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies Lancet 360 119 129
5. JA Bartlett R DeMasi J Quinn C Moxham F Rousseau 2001 Overview of the effectiveness of triple combination therapy in antiretroviral-naïve HIV-1 infected adults AIDS 15 1369 1377
6. C Laurent N Diakhaté NFN Gueye MA Touré PS Sow MA Faye M Gueye I Lanièce C Touré Kane F Liégeois L Vergne S Mboup S Badiane I Ndoye E Delaporte 2002 The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study AIDS 16 1363 1370
7. D Coetzee K Hildebrand A Boulle G Maartens F Louis V Labatala H Reuter N Ntwana E Goemaere 2004 Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa AIDS 18 887 895
8. K Wools-Kaloustian S Kimaiyo L Diero A Siika J Sidle CT Yiannoutsos B Musick R Einterz KH Fife WM Tierney 2006 Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya AIDS 20 41 48
9. P Severe P Leger M Charles F Noel G Bonhomme G Bois E George S Kenel-Pierre PF Wright R Gulick WD Johnson Jr JW Pape DW Fitzgerald 2005 Antiretroviral therapy in a thousand patients with AIDS in Haiti N Engl J Med 353 2325 2334
10. L Ferradini A Jeannin L Pinoges J Izopet D Odhiambo L Mankhambo G Karungi E Szumilin S Balandine G Fedida MP Carrieri B Spire N Ford JM Tassie PJ Guerin C Brasher 2006 Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment Lancet 367 1335 1342
11. DART Virology Group and Trial Team 2006 Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa AIDS 20 1391 1399
12. World Health Organization (WHO) (2006) Progress on global access to HIV antiretroviral therapy. A report on "3by5" and beyond, March, 2006. Available online at: http://www.who.int/hiv/fullreport_en_highres.pdf
13. V Hosegood AM Vanneste IM Timaeus 2004 Levels and causes of adult mortality in rural South Africa: the impact of AIDS AIDS 18 663 671
14. Human Sciences Research Council of South Africa (2005) The South African national HIV prevalence, HIV incidence, behaviour and communication survey, 2005. Available online at: http://www.hsrc.ac.za/media/2005/11/ 20051130_1Factsheet2.html
15. Department of Health, Republic of South Africa (2004) National HIV and syphilis antenatal sero-prevalence survey in South Africa, 2004. Available online at: http://www.doh.gov.za/docs/reports/2004/hiv-syphilis02.pdf
16. National Department of Health, South Africa (2004) National antiretroviral treatment guideline, 2004. Available online at: http://hivinsite.ucsf.edu/doc/cr09-sf-01.doc
17. LC Ivers D Kendrick K Doucette 2005 Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature Clin Infect Dis 41 217 224
18. RM Gulick HJ Ribaudo CM Shikuma C Lalama BR Schackman WA Meyer 3rd EP Acosta J Schouten KE Squires CD Pilcher RL Murphy SL Koletar M Carlson RC Reichman B Bastow KL Klingman DR Kuritzkes AIDS Clinical Trials Group (ACTG) A5095 Study Team 2006 Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial JAMA 296 769 781
19. JE Gallant E DeJesus JR Arribas AL Pozniak B Gazzard RE Campo B Lu D McColl S Chuck J Enejosa JJ Toole AK Cheng 2006 Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV N Engl J Med 354 251 260
20. ART-LINC Collaboration and ART-CC groups 2006 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries Lancet 367 817 824
21. MA van der Sande MF Schim van Der Loeff AA Aveika S Sabally T Togun R Sarge-Njie AS Alabi A Jaye T Corrah HC Whittle 2004 Body mass index at time of HIV diagnosis: a strong and independent predictor of survival J Acquir Immune Defic Syndr 37 1288 1294
22. W Van Damme K Kober M Laga 2006 The real challenges for scaling up ART in sub-Saharan Africa AIDS 20 653 656
23. N Nattrass 2006 South Africa's "rollout" of highly active antiretroviral therapy: a critical assessment J Acquir Immune Defic Syndr 43 618 623
24. Coetzee C, Nattrass N (2004) Living on AIDS treatment: a socio-economic profile of Africans receiving antiretroviral therapy in Khayelitsha, Cape Town. CSSR Working paper no. 04/071. Available online at: http://www.cssr.uct.ac.za/ pubs_cssr.asp
25. DP O'Brien D Sauvageot R Zachariah P Humblet Medecins Sans Frontieres 2006 In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy AIDS 20 1955 1960
26. KC Chan B Yip RS Hogg JS Montaner MV O'Shaughnessy 2002 Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States AIDS 16 1693 1695
27. C Erikstrup P Kallestrup R Zinyama E Gomo B Mudenge J Gerstoft H Ullum 2007 Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa J Acquir Immune Defic Syndr 44 4 478 483
28. M Badri S Cleary G Maartens J Pitt LG Bekker C Orrell R Wood 2006 When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study Antivir Ther 11 63 72
29. SP Koenig DR Kuritzkes MS Hirsch F Léandre JS Mukherjee PE Farmer C del Rio 2006 Monitoring HIV treatment in developing countries BMJ 332 602 604
30. R Colebunders KR Moses J Laurence HM Shihab F Semitala F Lutwama S Bakeera-Kitaka L Lynen L Spacek SJ Reynolds TC Quinn B Viner H Mayanja-Kizza 2006 A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries Lancet Infect Dis 6 53 59
31. Basenero A, Castelnuovo B, Birabwa E, John L, MacAdam K, Schlech W, Kambugu A (2007) Inadequacy of clinical and immunological criteria in identifying virologic failure of 1st line ART: the Ugandan experience. In: Program and abstracts of the 4th International Aids Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia July, 2007, abstract WEAB102
32. Hosseinipour M, van Oosterhout J, Weigel R, Mzigangira D, Saukila N, Mhango B, Phiri R, Phiri S, Kumwenda J (2007) Validating clinical and immunological definitions of antiretroviral treatment failure in Malawi. In: Program and abstracts of the 4th International Aids Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia, July 2007, abstract WEAB101
33. S Mannheimer G Friedland J Matts C Child M Chesney 2002 The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials Clin Infect Dis 34 1115 1121
34. L Osterberg T Blaschke 2005 Adherence to medication N Engl J Med 353 487 497
35. EJ Mills JB Nachega I Buchan J Orbinski A Attaran S Singh B Rachlis P Wu C Cooper L Thabane K Wilson GH Guyatt DR Bangsberg 2006 Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis JAMA 296 679 690